Randomized, Open-Label Phase II Study of Motesanib or Bevacizumab in Combination with Paclitaxel and Carboplatin (P/C) for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC)
Refereed conference paper presented and published in conference proceedings

香港中文大學研究人員

全文

其它資訊
著者BLUMENSCHEIN R. G., KABBINAVAR F. F., MENON H., MOK Shu Kam Tony, STEPHENSON J., BECK T. J., LAKSHMAIAH K., KRACHT K., SIKORSKI S. R., SCHWARTZBERG S. L.
會議名稱ASCO Annual Meeting 2010
會議國家/地區美國
會議論文集題名ASCO Annual Meeting 2010
詳細描述organized by American Society of Clinical Oncology,
出版年份2010
月份6
出版地United States of America
頁次7528
語言英式英語
關鍵詞Bevacizumab; Paclitaxel/carboplatin; NSCLC

上次更新時間 2021-07-05 於 11:13